Profile for European Patent Office Patent: 1135391
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Netherlands | C300485 | ⤷ Start Trial |
| Denmark | CA 2011 00013 | ⤷ Start Trial |
| Lithuania | PA2011004 | ⤷ Start Trial |
| Luxembourg | 91819 | ⤷ Start Trial |
| Lithuania | PA2011004,C1135391 | ⤷ Start Trial |
| Sweden | 1190009-9 | ⤷ Start Trial |
| France | 11C0016 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1135391
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
